MOSCOW (Sputnik) - The EpiVacCorona vaccine against the coronavirus, developed by Russia's Vector research centre, creates immunity one month after the inoculation, Alexander Ryzhikov, the head
MOSCOW (Sputnik) - The EpiVacCorona vaccine against the coronavirus, developed by Russia's Vector research centre, creates immunity one month after the inoculation, Alexander Ryzhikov, the head
MOSCOW (Sputnik) - The EpiVacCorona vaccine against the coronavirus, developed by Russia's Vector research centre, creates immunity one month after the inoculation, Alexander Ryzhikov, the head
MOSCOW (Sputnik) - The EpiVacCorona vaccine against the coronavirus, developed by Russia's Vector research centre, creates immunity one month after the inoculation, Alexander Ryzhikov, the head
MOSCOW (Sputnik) - The EpiVacCorona vaccine against the coronavirus, developed by Russia's Vector research centre, creates immunity one month after the inoculation, Alexander Ryzhikov, the head
MOSCOW (Sputnik) - The EpiVacCorona vaccine against the coronavirus, developed by Russia's Vector research centre, creates immunity one month after the inoculation, Alexander Ryzhikov, the head
MOSCOW (Sputnik) - The EpiVacCorona vaccine against the coronavirus, developed by Russia's Vector research centre, creates immunity one month after the inoculation, Alexander Ryzhikov, the head
BRUSSELS (Sputnik) - The European Medicines Agency (EMA) is in talks with the manufacturer of Russia's Sputnik V vaccine against the coronavirus following the vaccine developer reaching out to t
BRUSSELS (Sputnik) - The European Medicines Agency (EMA) is in talks with the manufacturer of Russia's Sputnik V vaccine against the coronavirus following the vaccine developer reaching out to t
BRUSSELS (Sputnik) - The European Medicines Agency (EMA) is in talks with the manufacturer of Russia's Sputnik V vaccine against the coronavirus following the vaccine developer reaching out to t
